- CRS Publications
- News
News
Authors:
Date:
Business Wire: May 12, 2016 – PARIS, France, and STANS, Switzerland – NLS Pharma Group announced the submission of an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a phase IIb clinical trial with its lead compound Mazindol. The study is…
Authors:
Date:
This first wave of computational modeling in pharmaceutical science was the application of informatics-based methods to finding optimum drug molecule structures: drug design. We can now move beyond this, both from drug design to the design of drug delivery vehicles, nanomedicine, and from raw…
Authors:
Date:
Business Wire: August 15, 2016 – LOUGHBOROUGH, England – Nemaura Pharma has been awarded the prestigious 2016 Frost & Sullivan award for best practices in enabling technology leadership in the transdermal drug delivery industry.
The analysts stated that “Nemaura Pharma’s drug delivery…
Authors:
Date:
PRNewswire: July 17, 2017 – BOSTON, MA, U.S.A. – The Luye Life Sciences Group announced today the opening of its new Boston R&D Center, the second global R&D facility set up in the United States after the one in New Jersey. The Boston R&D Center will collaborate with multiple business…
Authors:
Date:
Christiana Care Health System: September 12, 2017 – Wilmington, DE, U.S.A. – To accelerate the development of next-generation cancer therapies, the Gene Editing Institute of the Helen F. Graham Cancer Center & Research Institute at Christiana Care Health System has agreed to provide genetically…
Authors:
Introduction
The potent antioxidative effect of flavonoids can be used in cosmetic products to prevent skin from aging and wrinkles, provided a sufficiently high skin penetration can be obtained by the dermal…
